GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Asset Turnover

Schott Pharma AG KGaA (WBO:1SXP) Asset Turnover : 0.16 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Schott Pharma AG KGaA's Revenue for the three months ended in Dec. 2024 was €229.8 Mil. Schott Pharma AG KGaA's Total Assets for the quarter that ended in Dec. 2024 was €1,461.0 Mil. Therefore, Schott Pharma AG KGaA's Asset Turnover for the quarter that ended in Dec. 2024 was 0.16.

Asset Turnover is linked to ROE % through Du Pont Formula. Schott Pharma AG KGaA's annualized ROE % for the quarter that ended in Dec. 2024 was 14.27%. It is also linked to ROA % through Du Pont Formula. Schott Pharma AG KGaA's annualized ROA % for the quarter that ended in Dec. 2024 was 7.91%.


Schott Pharma AG KGaA Asset Turnover Historical Data

The historical data trend for Schott Pharma AG KGaA's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Asset Turnover Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Asset Turnover
0.98 0.97 0.85 0.74 0.72

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.18 0.18 0.17 0.16

Competitive Comparison of Schott Pharma AG KGaA's Asset Turnover

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Asset Turnover falls into.


;
;

Schott Pharma AG KGaA Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Schott Pharma AG KGaA's Asset Turnover for the fiscal year that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2024 )/( (Total Assets (A: Sep. 2023 )+Total Assets (A: Sep. 2024 ))/ count )
=957.091/( (1231.828+1442.269)/ 2 )
=957.091/1337.0485
=0.72

Schott Pharma AG KGaA's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=229.841/( (1442.269+1479.646)/ 2 )
=229.841/1460.9575
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Schott Pharma AG KGaA  (WBO:1SXP) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Schott Pharma AG KGaA's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=115.576/810.0045
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(115.576 / 919.364)*(919.364 / 1460.9575)*(1460.9575/ 810.0045)
=Net Margin %*Asset Turnover*Equity Multiplier
=12.57 %*0.6293*1.8036
=ROA %*Equity Multiplier
=7.91 %*1.8036
=14.27 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Schott Pharma AG KGaA's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=115.576/1460.9575
=(Net Income / Revenue)*(Revenue / Total Assets)
=(115.576 / 919.364)*(919.364 / 1460.9575)
=Net Margin %*Asset Turnover
=12.57 %*0.6293
=7.91 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Schott Pharma AG KGaA Asset Turnover Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines